Themis Medicare P/E Ratio
Themis Medicare P/E ratio. Themis Medicare (THEMISMED) P/E ratio is 26.29 (High), EPS (TTM) ₹0.12, current price ₹112.89 on NSE vs historical average P/E of 8.75 (83.3th percentile) — High - Growth expectations or overvalued. Examine THEMISMED earnings for recent quarterly revenue, profit and EPS trends.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
THEMISMED P/E Ratio — Valuation Signal & Historical Context
Themis Medicare P/E 26.29 vs historical average 8.75, range 0.47–43.86 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see THEMISMED share price screener.
- Stock appears overvalued with PE of 26.29, suggesting caution for new investments
- Current PE is 200.6% above historical average
- Trading at discount to sector average PE of 56.34
Themis Medicare P/E Ratio Historical Trend
THEMISMED annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 26.29 vs historical average 8.75. Also explore THEMISMED share price data to track price trends across different timeframes.
THEMISMED Historical P/E Ratio — EPS, Year-End Price & Valuation
Themis Medicare annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 43.86 | 5.01 | ₹219.75 | NSE | High |
| 2023 | 3.32 | 42.0 | ₹139.60 | NSE | Low |
| 2022 | 1.53 | 63.53 | ₹96.90 | NSE | Low |
| 2021 | 0.47 | 77.18 | ₹36.00 | NSE | Low |
| 2020 | 0.88 | 38.01 | ₹33.35 | NSE | Low |
| 2016 | 2.42 | 21.33 | ₹51.60 | NSE | Low |
THEMISMED vs Healthcare Peers — P/E Ratio Comparison
Themis Medicare P/E 26.29 vs Healthcare average 56.34, median 32.5 — range 2.04–740.29.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |